Association between dynapenic obesity and risk of cardiovascular disease: The Hisayama study

被引:4
作者
Setoyama, Yu [1 ,2 ]
Honda, Takanori [1 ,3 ]
Tajimi, Takahiro [1 ,2 ]
Sakata, Satoko [1 ,3 ,4 ]
Oishi, Emi [1 ,3 ,4 ]
Furuta, Yoshihiko [1 ,4 ]
Shibata, Mao [1 ,3 ]
Hata, Jun [3 ,5 ]
Kitazono, Takanari [3 ,4 ]
Nakashima, Yasuharu [2 ]
Ninomiya, Toshiharu [1 ,3 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Epidemiol & Publ Hlth, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan
[3] Kyushu Univ, Ctr Cohort Studies, Grad Sch Med Sci, 3-1-1,Maidashi,Higashi Ku, Fukuoka 8128582, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan
[5] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka, Japan
关键词
Body mass index; Cardiovascular disease; Dynapenic obesity; Handgrip strength; SARCOPENIC-OBESITY; OLDER-ADULTS; MUSCLE MASS; MORTALITY; POPULATION; DEFINITION; DIAGNOSIS; STRENGTH; UPDATE; HEALTH;
D O I
10.1002/jcsm.13564
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Dynapenic obesity is a condition characterized by high adiposity levels combined with muscle dysfunction. Although high adiposity and muscle loss/dysfunction are thought to synergistically increase the risk of cardiovascular disease (CVD), few studies have addressed the association between dynapenic and sarcopenic obesity and CVD. We aimed to investigate the association of dynapenic obesity with incident CVD events using the data from a population-based prospective longitudinal study in Japan. Methods A total of 2490 community-dwelling Japanese aged 40-79 years (42.5% males, mean age 57.7 +/- 10.6 years) without a history of CVD were followed up for a median of 24 years. Handgrip strength was classified as low, medium, or high by age- and sex-specific tertiles. Body mass index (BMI) levels were categorized as lean (<18.5 kg/m2), normal (18.5-24.9 kg/m2), or obese (>= 25.0 kg/m2). Dynapenic obesity was defined as having both low handgrip strength and obesity. The outcomes were defined as the first-ever development of CVD (defined as stroke or coronary heart disease). The hazard ratios (HRs) and their 95% confidence intervals (CIs) for the development of CVD were estimated using a Cox proportional hazards model, in which participants with high handgrip strength and normal BMI were used as a reference group. Mediation analyses used serum high-sensitivity C-reactive protein (hs-CRP) and homeostatic model assessment for insulin resistance (HOMA-IR) as mediators. Results During the follow-up period, 482 participants developed CVD events (324 cases of stroke and 209 of coronary heart disease). The multivariable-adjusted risk of CVD increased significantly among participants with dynapenic obesity compared with the reference group (HR 1.49, 95% CI 1.03-2.17). An analysis by age groups showed a further increase in the risk of CVD among participants with dynapenic obesity aged less than 65 years (HR 1.66, 95% CI 1.04-2.65). In mediation analyses for participants aged less than 65 years, serum hs-CRP was shown to be a significant mediator explaining 13.8% of the association between dynapenic obesity and the development of CVD, while HOMA-IR explained 12.2% of this relationship. Conclusions Dynapenic obesity was a significant risk factor for the development of CVD in a general Japanese population. This association was more pronounced among those aged <65 years. Inflammation, and possibly glucose metabolism, might partly mediate this association. Our findings suggest that preventing muscle dysfunction as well as appropriate weight control, especially in middle-age, are important for preventing the development of CVD.
引用
收藏
页码:2338 / 2348
页数:11
相关论文
共 41 条
  • [31] Dynapenic Abdominal Obesity as a Predictor of Worsening Disability, Hospitalization, and Mortality in Older Adults: Results From the InCHIANTI Study
    Rossi, Andrea P.
    Bianchi, Lara
    Volpato, Stefano
    Bandinelli, Stefania
    Guralnik, Jack
    Zamboni, Mauro
    Ferrucci, Luigi
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2017, 72 (08): : 1098 - 1104
  • [32] Sarcopenic Obesity and Endocrinal Adaptation with Age
    Sakuma, Kunihiro
    Yamaguchi, Akihiko
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [33] Obesity and muscle strength as long-term determinants of all-cause mortality-a 33-year follow-up of the Mini-Finland Health Examination Survey
    Stenholm, S.
    Mehta, N. K.
    Elo, I. T.
    Heliovaara, M.
    Koskinen, S.
    Aromaa, A.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2014, 38 (08) : 1126 - 1132
  • [34] Sarcopenic-obesity and cardiovascular disease risk in the elderly
    Stephen, W. C.
    Janssen, I.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2009, 13 (05) : 460 - 466
  • [35] United Nations Department of Economic and Social Affairs, 2020, Population Division
  • [36] SAS Macro for Causal Mediation Analysis with Survival Data
    Valeri, Linda
    VanderWeele, Tyler J.
    [J]. EPIDEMIOLOGY, 2015, 26 (02) : E23 - E24
  • [37] Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
    von Haehling, Stephan
    Coats, Andrew J. S.
    Anker, Stefan D.
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (06) : 2259 - 2261
  • [38] World Health Organization, 2000, The AsiaPacific Perspective: Redefining Obesity and its Treatment
  • [39] Sarcopenic obesity: A new category of obesity in the elderly
    Zamboni, Mauro
    Mazzali, Gloria
    Fantin, Francesco
    Rossi, Andrea
    Di Francesco, Vincenzo
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (05) : 388 - 395
  • [40] Zhang XM, 2019, BMC CANCER, V19, DOI [10.1186/s12877-019-1195-y, 10.1186/s12885-019-5273-5]